Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Angeli

Showing results (11-20 of 157) with videos related to

Pageof 16
Sort By:
The American Journal of Physiology|August 1, 1995
Stimulation of cholinergic receptors in the medial preoptic area affects sleep and cortical temperatureL Imeri, S Bianchi, P Angeli, et al.
Neuroreport|July 1, 1991
Differential effects of M2 and M3 muscarinic antagonists on the sleep-wake cycleL Imeri, S Bianchi, P Angeli, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 1, 1993
The influence of the muscarinic receptor subtypes on the sleep-wake cycleP Angeli, S Bianchi, L Imeri, et al.
Life Sciences|May 5, 1986
Thiol group may be involved in the irreversible blockade of presynaptic alpha 2-adrenoreceptors by pyrextramine and benextramine in the isolated guinea pig ileumL Brasili, A Cassinelli, P Angeli, et al.
Journal of Hepatology|August 29, 1998
Insulin-like growth factor 1 (IGF-1) in liver cirrhosis: a marker of hepatocellular dysfunction?L Caregaro, F Alberino, P Angeli, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|October 1, 1993
Cardiac involvement in liver cirrhosisA Gatta, C Merkel, D Sacerdoti, et al.
European Journal of Pharmacology|August 3, 1984
N,N''-(dithio-2,1-ethanediyl)bis[N'-(pyrrol-2-ylmethyl)-1, 6,- hexanediamine] (pyrextramine), a new irreversible alpha 1-adrenoreceptor blocking agent of the tetramine disulfide classL Brasili, P Angeli, E Brancia, et al.
Neuroreport|March 1, 1992
M1 and M3 muscarinic receptors: specific roles in sleep regulationL Imeri, S Bianchi, P Angeli, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1995
Selective blockade of muscarinic M2 receptors in vivo by the new antagonist tripitramineP Angeli, F Cantalamessa, U Gulini, et al.
Journal of Pharmaceutical Sciences|May 1, 1981
Molecular requirements of the active site of cholinergic receptors XV: Synthesis and biological activity of 2,3-dehydrodeoxamuscarone and 2,3-dehydrodeoxamuscarinesP Angeli, L Brasili, D Giardinà, et al.
Pageof 16

Showing results (11-20 of 157) with videos related to

Sort By:
Pageof 16
The American Journal of Physiology|August 1, 1995
Stimulation of cholinergic receptors in the medial preoptic area affects sleep and cortical temperatureL Imeri, S Bianchi, P Angeli, et al.
Neuroreport|July 1, 1991
Differential effects of M2 and M3 muscarinic antagonists on the sleep-wake cycleL Imeri, S Bianchi, P Angeli, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 1, 1993
The influence of the muscarinic receptor subtypes on the sleep-wake cycleP Angeli, S Bianchi, L Imeri, et al.
Life Sciences|May 5, 1986
Thiol group may be involved in the irreversible blockade of presynaptic alpha 2-adrenoreceptors by pyrextramine and benextramine in the isolated guinea pig ileumL Brasili, A Cassinelli, P Angeli, et al.
Journal of Hepatology|August 29, 1998
Insulin-like growth factor 1 (IGF-1) in liver cirrhosis: a marker of hepatocellular dysfunction?L Caregaro, F Alberino, P Angeli, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|October 1, 1993
Cardiac involvement in liver cirrhosisA Gatta, C Merkel, D Sacerdoti, et al.
European Journal of Pharmacology|August 3, 1984
N,N''-(dithio-2,1-ethanediyl)bis[N'-(pyrrol-2-ylmethyl)-1, 6,- hexanediamine] (pyrextramine), a new irreversible alpha 1-adrenoreceptor blocking agent of the tetramine disulfide classL Brasili, P Angeli, E Brancia, et al.
Neuroreport|March 1, 1992
M1 and M3 muscarinic receptors: specific roles in sleep regulationL Imeri, S Bianchi, P Angeli, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1995
Selective blockade of muscarinic M2 receptors in vivo by the new antagonist tripitramineP Angeli, F Cantalamessa, U Gulini, et al.
Journal of Pharmaceutical Sciences|May 1, 1981
Molecular requirements of the active site of cholinergic receptors XV: Synthesis and biological activity of 2,3-dehydrodeoxamuscarone and 2,3-dehydrodeoxamuscarinesP Angeli, L Brasili, D Giardinà, et al.
Pageof 16